In vivo activation of STAT3 in cutaneous T-cell lymphoma. Evidence for an antiapoptotic function of STAT3

[1]  Heinz Baumann,et al.  Signal transducer and activator of transcription proteins in leukemias. , 2003, Blood.

[2]  B. Thiers,et al.  Cutaneous T‐cell lymphoma , 2003, Journal of the European Academy of Dermatology and Venereology : JEADV.

[3]  J. Darnell,et al.  Signalling: STATs: transcriptional control and biological impact , 2002, Nature Reviews Molecular Cell Biology.

[4]  D. Frank,et al.  The role of STATs in apoptosis. , 2002, Current molecular medicine.

[5]  D. Levy,et al.  What does Stat3 do? , 2002, The Journal of clinical investigation.

[6]  C. Geisler,et al.  Spontaneous interleukin-5 production in cutaneous T-cell lymphoma lines is mediated by constitutively activated Stat3. , 2002, Blood.

[7]  Qian Zhang,et al.  Multilevel Dysregulation of STAT3 Activation in Anaplastic Lymphoma Kinase-Positive T/Null-Cell Lymphoma1 , 2002, The Journal of Immunology.

[8]  D. Levy,et al.  What does Stat 3 do ? , 2002 .

[9]  D. Hilton,et al.  Negative regulation of cytokine signaling , 2001, Journal of leukocyte biology.

[10]  C. Geisler,et al.  Constitutive STAT3-activation in Sezary syndrome: tyrphostin AG490 inhibits STAT3-activation, interleukin-2 receptor expression and growth of leukemic Sezary cells , 2001, Leukemia.

[11]  W. Alexander,et al.  Negative Regulators of Cytokine Signaling , 2001, International journal of hematology.

[12]  C. Geisler,et al.  Interferon-Alpha Induces Transient Suppressors of Cytokine Signalling Expression in Human T Cells , 2001, Experimental and Clinical Immunogenetics.

[13]  M. Wasik,et al.  STAT3-mediated constitutive expression of SOCS-3 in cutaneous T-cell lymphoma. , 2001, Blood.

[14]  S. Akira,et al.  STAT family of transcription factors in cytokine-mediated biological responses. , 2000, Cytokine & growth factor reviews.

[15]  Simon C Watkins,et al.  Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Bromberg.  Signal transducers and activators of transcription as regulators of growth, apoptosis and breast development , 2000, Breast Cancer Research.

[17]  S. Akira,et al.  Suppression of epithelial apoptosis and delayed mammary gland involution in mice with a conditional knockout of Stat3. , 1999, Genes & development.

[18]  C. Geisler,et al.  Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[19]  S. Akira,et al.  Keratinocyte‐specific ablation of Stat3 exhibits impaired skin remodeling, but does not affect skin morphogenesis , 1999, The EMBO journal.

[20]  J. Darnell,et al.  Stat3 as an Oncogene , 1999, Cell.

[21]  C. Geisler,et al.  Inhibition of constitutively activated Stat3 correlates with altered Bcl-2/Bax expression and induction of apoptosis in mycosis fungoides tumor cells , 1999, Leukemia.

[22]  J. Turkson,et al.  Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells. , 1999, Immunity.

[23]  M. Heim.  The Jak-STAT pathway: cytokine signalling from the receptor to the nucleus. , 1999, Journal of receptor and signal transduction research.

[24]  E. Samuelson.  Cutaneous T-cell lymphomas. , 1998, Seminars in oncology nursing.

[25]  J. Hackney,et al.  STAT3 activation accompanies keratinocyte differentiation. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[26]  S. Akira,et al.  Stat3 activation is responsible for IL-6-dependent T cell proliferation through preventing apoptosis: generation and characterization of T cell-specific Stat3-deficient mice. , 1998, Journal of immunology.

[27]  T. Mustelin,et al.  Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[28]  T. Hirano,et al.  Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: involvement of STAT3 in anti-apoptosis. , 1996, Immunity.

[29]  Philip R. Cohen,et al.  Mycosis fungoides and Sezary syndrome. , 1996, Blood.

[30]  P. Nowell,et al.  Activation of Jak/STAT proteins involved in signal transduction pathway mediated by receptor for interleukin 2 in malignant T lymphocytes derived from cutaneous anaplastic large T-cell lymphoma and Sezary syndrome. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[31]  T. Hirano,et al.  A central role for Stat3 in IL‐6‐induced regulation of growth and differentiation in M1 leukemia cells. , 1996, The EMBO journal.

[32]  S. Akira,et al.  STAT3 activation is a critical step in gp130-mediated terminal differentiation and growth arrest of a myeloid cell line. , 1996, Proceedings of the National Academy of Sciences of the United States of America.